Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype - Wikidata - wikimedia - TriplyDB

Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype

Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype

http://www.wikidata.org/entity/Q26779198

about

Adenosine receptors: regulatory players in the preservation of mitochondrial function induced by ischemic preconditioning of rat liver.Post hepatectomy liver failure - A comprehensive review of current concepts and controversies

P2860

Q41929342-AF6DEFEE-CE4F-4A28-97F4-27C9C0960472 Q58712022-05828964-E3E7-4B53-810B-587BFE9C6FBB

P2860

Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype

http://www.wikidata.org/entity/Q26779198

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@ast

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@en

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@nl

type

label

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@ast

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@en

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@nl

prefLabel

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@ast

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@en

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@nl

P1433

Q26779198-15C42C0C-CBD5-499A-8A5C-5922467A8208

P1476

Q26779198-5DB8BBF0-DCB7-46A7-B19C-A5F84D46D455

P2093

Q26779198-5C21A915-F028-494B-8C44-18F7752A767B

Q26779198-60FA63C9-EF89-4AC2-892A-06CE6688C3E8

Q26779198-6DE3CBE8-2026-4B0A-9039-A4A07EA0920D

Q26779198-B4A78C13-A7AA-4AF2-AD96-BAC0BB74B6C2

Q26779198-D7BBED4C-0720-4A90-938D-0AEE788563DE

Q26779198-EA3A8B4D-85C7-450E-84DA-E451032AD4EC

P275

Q26779198-6BE78E68-8B88-49F1-B6BD-250E116882A3

P2860

Q26779198-05DA1BBF-F889-480C-B0EA-579C4F113932

Q26779198-0A319B9D-2D81-4C5B-AB30-794D5B1455D1

Q26779198-0AD047AC-C32E-4C5E-83E0-35EAD7DDE872

Q26779198-0EE5E69F-E199-4E4C-8390-34F9D7432B15

Q26779198-167C930C-E503-44CF-92DA-DF671D80517A

Q26779198-1CA9B3C1-6BD3-40F4-93D0-727B8B6DB727

Q26779198-1FEFBFBF-13DC-4866-925D-9273E6238ACA

Q26779198-242913A2-6DB8-4045-9DA9-8BA819531363

Q26779198-2A56FABB-D249-4B44-BF9D-0AD1A4C2C667

Q26779198-2ADB8F9D-C9CC-411F-B213-89CE648F86BE

P304

Q26779198-A9845DA2-5977-4114-92A2-6F4464DD8374

P31

Q26779198-9F89B8C3-F581-44E9-9416-AEF2C360E72B

P356

Q26779198-3BB633AD-C1F6-49E5-B556-A56D6A20DE69

P407

Q26779198-EA4E5253-D5AE-4219-A4C7-5C04C35273C7

P478

Q26779198-A88110AE-7207-4138-B22E-B4306E28784B

P50

Q26779198-0D44FBE1-1128-4E4E-A6AA-C8320ADB2C4D

Q26779198-2CD46753-CB12-44F3-B9D8-CBC1CF42FB5B

P577

Q26779198-5E11BC02-48F2-464F-B3B3-1F128BEDDFC7

P5875

Q26779198-2663AAB9-0B5D-45C6-A57D-0BECB2D74DAA

P698

Q26779198-57621F64-28FC-4525-BF26-17C27B6BA524

P921

Q26779198-15430420-E658-4538-955E-B6A6E871BC03

Q26779198-7F9C558A-8F8E-41C4-B0B5-72B1DFD0ED2E

Q26779198-9D992ECF-156C-4286-BF41-F9D434FB01A4

Q26779198-A0C048A9-1587-40FD-87BE-FA2946ACD22E

Q26779198-ED1CE524-C2DE-4129-9B4D-4746C49BCBBB

P932

Q26779198-FCCB54F9-78E2-4D51-A503-EE60FFC6B383

P356

P1433

BioMed Research International

P1476

Pharmacological Preconditionin ...... Protected Liver Cell Phenotype

@en

P2093

Antonia Follenzi

http://www.w3.org/2001/XMLSchema#string

Bangalore R Chandrashekar

http://www.w3.org/2001/XMLSchema#string

Chiara Imarisio

http://www.w3.org/2001/XMLSchema#string

Elisa Alchera

http://www.w3.org/2001/XMLSchema#string

Giorgia Mandili

http://www.w3.org/2001/XMLSchema#string

Rita Carini

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Adenosine preconditioning attenuates hepatic reperfusion injury in the rat by preventing the down-regulation of endothelial nitric oxide synthase.

Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species

Recent developments in adenosine receptor ligands and their potential as novel drugs

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury.

Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.

Effect of ischaemic preconditioning on hepatic oxygenation, microcirculation and function in a rat model of moderate hepatic steatosis.

The preconditioning phenomenon: A tool for the scientist or a clinical reality?

Nonalcoholic steatohepatitis: definition and pathology.

Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.

P304

286746

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/286746

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Novelli

P577

2015-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283954275

http://www.w3.org/2001/XMLSchema#string

P698

26539478

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

membrane proteins

physiological phenomena

P932

4619783

http://www.w3.org/2001/XMLSchema#string